Are you Dr. Hamiditabar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
27005 76th Ave
New Hyde Park, NY 11040Phone+1 516-470-7000
Publications & Presentations
PubMed
- 10 citationsSafety and Effectiveness of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy After Regional Hepatic Embolization in Patients With Somatostatin-Expressing Neuroendo...Mohammadali Hamiditabar, Muzammil Ali, Luke Bolek, Gelareh Vahdati, Izabela Tworowska
Clinical Nuclear Medicine. 2017-11-01 - 53 citationsPeptide Receptor Radionuclide Therapy With 177Lu-Octreotate in Patients With Somatostatin Receptor Expressing Neuroendocrine Tumors: Six Years' AssessmentMohammadali Hamiditabar, Muzammil Ali, Joseph Roys, Edward M. Wolin, Thomas M. O'Dorisio
Clinical Nuclear Medicine. 2017-06-01
